查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012525

吻合器市場：按技術、手術類型、材料、分銷管道、應用和最終用途分類－2026-2032年全球市場預測

Anastomosis Devices Market by Technology, Procedure Type, Material Type, Distribution Channel, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，吻合器市值將達到 32.5 億美元，到 2026 年將成長至 34.8 億美元，到 2032 年將達到 57.1 億美元，複合年成長率為 8.38%。

主要市場統計數據
基準年 2025 32.5億美元
預計年份：2026年 34.8億美元
預測年份 2032 57.1億美元
複合年成長率 (%) 8.38%

對現代吻合器市場進行全面概述，重點在於醫療保健系統的臨床促進因素、創新方向和採購重點。

吻合器械產業正處於一個十字路口，臨床上對改善手術效果的需求與器械層面的快速創新相互交織。本報告首先概述了當前的市場格局，外科醫生、醫院管理者和器械製造商都在努力應對日益複雜的臨床、監管和商業性因素。隨著器械人體工學、生物相容性材料和手術專用工具的不斷改進，相關人員正在修訂採購計畫和產品藍圖，以反映不斷變化的臨床偏好和手術流程。

對重塑吻合器市場競爭優勢和採用趨勢的技術、臨床和監管變化進行詳細分析。

吻合器材市場正經歷一場變革性的轉型，其促進因素包括技術進步、臨床實務以及供應鏈韌性。在技​​術層面，電動器材和智慧型裝置介面正在提升複雜吻合術的精準度和一致性。同時，生物可分解材料和複合材料的進步正在增強組織整合，並減少長期異物反應。這些技術變革並非孤立存在，而是正在影響培訓計畫、手術流程和器械維護模式，因此需要採取全面性的商業化策略。

對 2025 年美國新關稅政策將如何影響設備供應鏈中的製造地、分銷策略和採購趨勢進行了深入分析。

美國將於2025年實施新的關稅措施，將進一步增加醫療設備製造商和醫療保健系統採購商的供應鏈和定價策略的複雜性。關稅調整正在影響各個分銷管道的採購決策，迫使企業重新評估製造地，並影響供應商和醫療保健採購商之間的談判。為此，許多製造商正在探索近岸外包、區域組裝基地和採購多元化等策略，以緩解成本壓力，同時保持品管和前置作業時間的可靠性。

基於細分市場的詳細洞察，揭示了影響需求的臨床適應症、最終用途環境、技術類型、治療方法、分銷管道和材料選擇。

市場區隔提供了一個分析框架，用於理解創新與需求在臨床和商業性層面的交會點。基於應用領域，市場研究涵蓋心血管和消化器官系統外科領域，其中心血管領域進一步細分為冠狀動脈和血管，消化器官系統則細分為結直腸、食道和胃。這種結構突顯了臨床適應症如何決定醫療設備的設計重點，例如管腔尺寸相容性、加強策略和止血控制。基於最終用戶，市場調查涵蓋門診手術中心、醫院和專科診所等不同場所，揭示了受病例組成、資金預算和無菌資源等因素驅動的不同採購行為。

從戰略區域觀點審視美洲、歐洲、中東和非洲以及亞太地區不同的醫療保健系統，每個系統都需要量身定做的商業化策略和監管策略。

區域趨勢是產品開發、監管策略和商業部署策略規劃的核心。在美洲，醫療保健系統由先進的三級醫療機構和社區醫院組成，採購決策受到對整合式醫療網路、報銷模式和打包支付結果的重視。在這種環境下，擁有可靠的臨床核准和可擴展培訓計畫的系統更具優勢。在歐洲、中東和非洲，監管環境的差異以及醫院採購結構的多樣性促使製造商採取量身定做的打入市場策略，以平衡集中核准和本地夥伴關係。同時，特定市場的成本敏感度也推動了模組化產品和靈活商業模式的發展。

權威概述了競爭趨勢，展示了吻合解決方案的市場領導地位是如何由平台策略、臨床證據產生和策略夥伴關係關係決定的。

吻合器材領域的競爭動態由成熟的醫療設備製造商和靈活創新的專業公司共同塑造。主要企業致力於開發涵蓋器械、耗材和手術培訓的整合平台，並與外科團隊和醫院系統建立牢固的合作關係。這些公司正透過多中心研究和上市後註冊研究來累積臨床證據，以證明其產品性能優於同類產品，並為醫保報銷提供依據。同時，小規模、專注於技術的新興參與企業則憑藉其獨特的材料科學和自動化能力，致力於解決特定的臨床難題，開拓利基應用領域。

為醫療設備製造商提供切實可行的策略建議，以協調創新、臨床證據和穩健的經營模式，確保在所有醫療保健環境中永續應用。

產業領導企業應優先考慮整合產品創新與臨床工作流程、供應鏈韌性和實證醫學證據的整合方法。投資於電動設備平台和直覺的使用者介面，既能降低手術結果的差異性，又能使產品在醫院和門診環境中脫穎而出。同時，豐富材料組合，納入可生物分解材料和複合材料選項，可以滿足臨床醫生不同的偏好和長期安全性的擔憂。重要的是，製造商應建立臨床項目，產生可靠的真實世界數據和外科醫生主導的證據，以促進產品推廣應用並支持與保險公司的對話。

採用高度透明的調查方法，結合定性專家訪談、監管和臨床文獻審查以及情境分析，以檢驗策略結論和建議。

本研究結合了對外科專家、採購經理和醫療設備工程師的定性訪談，以及對監管申報文件、臨床文獻和醫療機構公開採購慣例的二次分析。調查方法強調跨資料來源的三角驗證，以確保研究結果既反映臨床實際情況，也考慮商業性限制。主要研究內容包括：透過結構化訪談了解醫療專業人員的偏好；對採購和培訓項目進行案例研究分析；以及對醫療設備設計和材料進行技術審查，以評估性能權衡。

結論強調，循證創新、供應鏈韌性和一體化商業化對於實現永續的臨床和商業性成功至關重要。

總之，吻合器材領域的特點是臨床創新、材料科學進步和不斷變化的商業性壓力之間存在著動態的互動關係。在這個市場取得成功，需要兼顧兩方面：一是提供可重複的手術性能，二是建構穩健的、基於實證醫學的商業模式，以適應不斷變化的區域法規和經濟狀況。將動力器材、多樣化的材料選擇和全面的臨床培訓項目整合到一致的價值提案的利益相關人員，將更有能力滿足臨床醫生的需求和醫療機構的採購標準。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：吻合器市場：依技術分類

  • 手動輸入
  • 電的

第9章：吻合器市場：依手術類型分類

  • 微創
  • 開放性手術

第10章 吻合器市場：依材料分類

  • 可生物分解
  • 複合材料
  • 鈦

第11章 吻合器市場：依通路分類

  • 直銷
  • 線上銷售
  • 第三方經銷商

第12章 吻合器市場：依應用領域分類

  • 心血管系統
    • 冠狀動脈
    • 血管
  • 消化器官系統
    • 大腸和直腸
    • 食道
    • 胃

第13章 吻合器市場：依最終用途分類

  • 門診手術中心
  • 醫院
  • 專科診所

第14章 吻合器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 吻合器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 吻合器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國：吻合器材市場

第18章 中國：吻合器械市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • Cook Medical LLC
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Peters Surgical Company, Inc.
  • Smiths Group plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-431F213C91D8

The Anastomosis Devices Market was valued at USD 3.25 billion in 2025 and is projected to grow to USD 3.48 billion in 2026, with a CAGR of 8.38%, reaching USD 5.71 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.25 billion
Estimated Year [2026] USD 3.48 billion
Forecast Year [2032] USD 5.71 billion
CAGR (%) 8.38%

Comprehensive introduction to the contemporary anastomosis devices landscape highlighting clinical drivers, innovation vectors, and procurement priorities for healthcare systems

The anastomosis devices sector stands at an inflection point as clinical demand for improved surgical outcomes converges with rapid device-level innovation. This report opens by framing the contemporary landscape in which surgeons, hospital administrators, and device manufacturers navigate an increasingly complex set of clinical, regulatory, and commercial considerations. Building on sustained improvements in instrument ergonomics, tissue-compatible materials, and procedure-specific tooling, stakeholders are recalibrating procurement and product road maps to reflect evolving clinical preferences and procedural workflows.

As minimally invasive techniques become standard of care across a widening range of cardiovascular and gastrointestinal procedures, device developers are responding with systems that emphasize reproducibility, reduced operative time, and enhanced tissue healing. Concurrently, payers and health systems are placing greater emphasis on value-based outcomes. Consequently, manufacturers must demonstrate not only technical performance but also integration with care pathways, training programs, and inventory management. This introduction establishes the core themes examined throughout the report and orients readers to the major drivers shaping near-term clinical adoption and commercial competition.

Detailed analysis of the technological, clinical, and regulatory shifts reshaping competitive advantage and adoption dynamics in the anastomosis devices market

The anastomosis devices landscape is undergoing transformative shifts driven by convergent forces in technology, clinical practice, and supply chain resilience. On the technology front, powered instrumentation and intelligent device interfaces are improving precision and consistency across complex anastomoses, while advances in biodegradable and composite materials are enhancing tissue integration and reducing long-term foreign body reactions. These technological shifts are not isolated; they influence training programs, procedural protocols, and device servicing models, necessitating a holistic approach to commercialization.

Clinically, surgeons are increasingly favoring techniques that minimize tissue trauma and shorten recovery, which has catalyzed broader adoption of minimally invasive approaches. As hospitals and ambulatory surgical centers refine perioperative pathways to optimize throughput and patient experience, device suppliers must align product development with the evolving cadence of care. Meanwhile, regulatory scrutiny and greater emphasis on post-market surveillance are elevating quality assurance and evidence-generation as commercial imperatives. Taken together, these trends are reshaping competitive advantage, where differentiation increasingly depends on a combination of clinical evidence, integrated services, and adaptable distribution models.

Insightful examination of how new United States tariff policies for 2025 are influencing manufacturing footprints, distribution strategies, and procurement dynamics in device supply chains

The introduction of new tariff measures in the United States for 2025 has introduced an added layer of complexity to supply chain and pricing strategies for device manufacturers and health system purchasers. Tariff adjustments influence procurement decisions across distribution channels, compel reassessment of manufacturing footprints, and shape negotiations between suppliers and institutional buyers. In response, many manufacturers are examining near-shoring, regional assembly hubs, and diversified sourcing to mitigate cost pressure while maintaining quality controls and lead-time reliability.

Beyond direct cost implications, tariffs can affect channel dynamics by altering the relative competitiveness of direct sales versus third-party distribution, and by incentivizing digital and online sales channels that reduce middle-tier costs. Healthcare providers are evaluating total cost of ownership with greater scrutiny, factoring in logistics risk, expected device longevity tied to material selection, and potential regulatory compliance costs. In short, tariff-driven shifts are reinforcing the importance of supply chain agility and contractual flexibility as central components of commercial strategy in the anastomosis devices sector.

In-depth segmentation-driven insights revealing clinical indications, end-use environments, technology types, procedure approaches, distribution channels, and material choices shaping demand

Segmentation provides the analytical framework to understand where innovation and demand converge across clinical and commercial axes. Based on application, the market is studied across cardiovascular and gastrointestinal procedures, with cardiovascular further divided into coronary and vascular, and gastrointestinal split into colorectal, esophageal, and gastric; this structure highlights how clinical indications drive device design priorities such as lumen size compatibility, reinforcement strategies, and hemostasis control. Based on end use, the market is studied across ambulatory surgical center, hospitals, and specialty clinic settings, revealing divergent procurement behaviors driven by case mix, capital budgets, and sterilization resources.

Drawing on technology segmentation, the market is studied across manual and powered solutions, enabling differential assessments of usability, training burden, and procedure time impacts. Based on procedure type, the market is studied across minimally invasive and open surgery approaches, which clarifies adoption trajectories as minimally invasive techniques continue to displace traditional open procedures for many indications. Based on distribution channel, the market is studied across direct sales, online sales, and third party distributors, which surfaces channel economics, service expectations, and aftermarket support requirements. Lastly, based on material type, the market is studied across biodegradable, composite, and titanium options to capture trade-offs between tissue compatibility, mechanical integrity, and long-term implant behavior. Together, these segmentations illuminate where clinical needs, reimbursement dynamics, and operational realities intersect to create pockets of opportunity and competitive pressure.

Strategic regional perspective on how diverse healthcare systems across the Americas, Europe Middle East & Africa, and Asia-Pacific require tailored commercialization tactics and regulatory strategies

Regional dynamics are central to strategic planning for product development, regulatory strategy, and commercial deployment. In the Americas, healthcare systems display a mix of advanced tertiary centers and community hospitals where purchasing decisions are influenced by integrated care networks, reimbursement models, and emphasis on bundled payment outcomes; this environment favors systems with robust clinical evidence and scalable training programs. In Europe, Middle East & Africa, regulatory heterogeneity and varying hospital procurement structures lead manufacturers to pursue tailored market entry strategies that balance centralized approvals with local partnerships, while cost-sensitivity in certain markets encourages modular product offerings and flexible commercial models.

Asia-Pacific markets present a diverse set of growth and adoption patterns driven by rising surgical capacity, expansion of minimally invasive programs, and government-led healthcare investments. Suppliers engaging these markets often combine localized manufacturing or assembly with collaborative training and clinical education initiatives to accelerate adoption. Across all regions, differences in supply chain resilience, tariff exposure, and distribution ecosystems require companies to adopt region-specific playbooks that integrate regulatory foresight, strategic partnerships, and adaptable pricing structures to succeed in a fragmented global landscape.

Authoritative overview of competitive dynamics showing how platform strategies, clinical evidence generation, and strategic partnerships determine market leadership in anastomosis solutions

Competitive dynamics in the anastomosis devices space are shaped by a mix of established medical device firms and agile specialized innovators. Leading companies are focusing on platform development that integrates instrumentation, consumables, and procedural training to create sticky relationships with surgical teams and hospital systems. These firms are investing in clinical evidence generation, often through multi-center studies and post-market registries, to demonstrate comparative performance and to support reimbursement discussions. At the same time, smaller, technology-focused entrants are pursuing niche applications with unique material science or automation features that address specific clinical pain points.

Partnerships and strategic alliances are increasingly common, enabling larger organizations to augment product portfolios with targeted technologies while providing scale and distribution reach. Concurrently, OEM and contract manufacturers are evolving from pure production partners into co-development collaborators, offering expertise in device engineering, regulatory navigation, and cost optimization. The overall competitive environment rewards companies that can combine clinical credibility with operational excellence in manufacturing, supply chain, and customer support.

Actionable strategic recommendations for device makers to align innovation, clinical evidence, and resilient commercial models to secure durable adoption across care settings

Industry leaders should prioritize an integrated approach that aligns product innovation with clinical workflows, supply chain resilience, and evidence generation. Investing in powered device platforms and intuitive user interfaces can reduce variance in surgical outcomes while differentiating offerings in hospital and ambulatory settings. In parallel, diversifying material portfolios to include biodegradable and composite options will address clinician preference variability and long-term safety considerations. Importantly, manufacturers should structure clinical programs that generate robust real-world data and surgeon-led evidence to support adoption and payer dialogue.

From an operational perspective, firms must reassess sourcing strategies to mitigate tariff exposure and logistics risk, including options for regional assembly and strategic vendor diversification. Commercially, tailoring distribution strategies to the needs of hospitals, ambulatory surgical centers, and specialty clinics will improve market penetration; this can include hybrid models combining direct specialist sales with online ordering options for high-turn consumables. Finally, investing in comprehensive training, proctoring, and value-based contracting will strengthen provider relationships and embed devices within care pathways, creating durable advantages in a competitive landscape.

Transparent research methodology combining qualitative expert interviews, regulatory and clinical literature review, and scenario analysis to validate strategic conclusions and recommendations

This study synthesizes primary qualitative interviews with surgical specialists, procurement leaders, and device engineers alongside secondary analysis of regulatory filings, clinical literature, and publicly available institutional procurement practices. The methodology emphasizes triangulation across data sources to ensure findings reflect both clinical realities and commercial constraints. Key inputs include structured interviews to surface practitioner preferences, case study analysis of procurement and training programs, and technical reviews of device designs and materials to assess performance trade-offs.

Analytical techniques incorporate comparative scenario analysis to evaluate impacts of tariff changes and distribution strategies, as well as segmentation mapping to identify high-priority application and end-use clusters. Quality assurance processes included source validation and expert review panels to corroborate interpretations and to refine recommended actions. This approach produces insights that are actionable for product development, go-to-market planning, and organizational design without relying on proprietary market sizing.

Concluding synthesis emphasizing the imperative for evidence-backed innovation, supply chain resilience, and integrated commercialization to achieve sustained clinical and commercial success

In conclusion, the anastomosis devices sector is characterized by dynamic interplay between clinical innovation, material science advances, and shifting commercial pressures. Success in this market requires a dual focus on delivering reproducible surgical performance and on building resilient, evidence-backed commercial models that can adapt to regional regulatory and economic variability. Stakeholders that integrate powered instrumentation, versatile material options, and strong clinical training programs into a coherent value proposition will be best positioned to meet clinician needs and institutional purchasing criteria.

Moving forward, companies should maintain agility in supply chain planning and prioritize partnerships that accelerate clinical acceptance. By aligning product road maps with the procedural trends toward minimally invasive care and by investing in the real-world evidence that buyers demand, manufacturers and investors can create sustainable competitive differentiation and support improved patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anastomosis Devices Market, by Technology

  • 8.1. Manual
  • 8.2. Powered

9. Anastomosis Devices Market, by Procedure Type

  • 9.1. Minimally Invasive
  • 9.2. Open Surgery

10. Anastomosis Devices Market, by Material Type

  • 10.1. Biodegradable
  • 10.2. Composite
  • 10.3. Titanium

11. Anastomosis Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Anastomosis Devices Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Coronary
    • 12.1.2. Vascular
  • 12.2. Gastrointestinal
    • 12.2.1. Colorectal
    • 12.2.2. Esophageal
    • 12.2.3. Gastric

13. Anastomosis Devices Market, by End Use

  • 13.1. Ambulatory Surgical Center
  • 13.2. Hospitals
  • 13.3. Specialty Clinic

14. Anastomosis Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anastomosis Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anastomosis Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Anastomosis Devices Market

18. China Anastomosis Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AtriCure, Inc.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardinal Health, Inc.
  • 19.11. ConMed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Getinge AB
  • 19.14. Intuitive Surgical, Inc.
  • 19.15. Johnson & Johnson
  • 19.16. LivaNova PLC
  • 19.17. Medtronic plc
  • 19.18. Meril Life Sciences Pvt. Ltd.
  • 19.19. Peters Surgical Company, Inc.
  • 19.20. Smiths Group plc
  • 19.21. Stryker Corporation
  • 19.22. Teleflex Incorporated
  • 19.23. Terumo Corporation
  • 19.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)